Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Current Protocols in Pharmacology|March 21, 2016
Overview of Genetically Engineered Mouse Models of Distinct Breast Cancer SubtypesJerry Usary, David Brian Darr, Adam D Pfefferle, et al.Breast Cancer Research and Treatment|January 11, 2015
Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapyAdam D Pfefferle, Benjamin T Spike, Geoff M Wahl, et al.Brain, Behavior and Evolution|October 12, 2011
A potential role for glucose transporters in the evolution of human brain sizeOlivier Fedrigo, Adam D Pfefferle, Courtney C Babbitt, et al.Cancer Research|May 4, 2012
Oncogenic PI3K mutations lead to NF-κB-dependent cytokine expression following growth factor deprivationJessica E Hutti, Adam D Pfefferle, Sean C Russell, et al.Plos One|September 9, 2010
A pipeline to determine RT-QPCR control genes for evolutionary studies: application to primate gene expression across multiple tissuesOlivier Fedrigo, Lisa R Warner, Adam D Pfefferle, et al.Oncotarget|May 14, 2015
c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expressionMichael A Cantrell, Nancy D Ebelt, Adam D Pfefferle, et al.Disease Models & Mechanisms|June 20, 2019
The MMTV-Wnt1 murine model produces two phenotypically distinct subtypes of mammary tumors with unique therapeutic responses to an EGFR inhibitorAdam D Pfefferle, David B Darr, Benjamin C Calhoun, et al.Journal of Human Evolution|December 31, 2010
Comparative expression analysis of the phosphocreatine circuit in extant primates: Implications for human brain evolutionAdam D Pfefferle, Lisa R Warner, Catrina W Wang, et al.Genome Biology and Evolution|March 25, 2010
Both noncoding and protein-coding RNAs contribute to gene expression evolution in the primate brainCourtney C Babbitt, Olivier Fedrigo, Adam D Pfefferle, et al.Disease Models & Mechanisms|May 7, 2016
Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancersAdam D Pfefferle, Yash N Agrawal, Daniel C Koboldt, et al.Pageof 3